These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23012630)

  • 21. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
    Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
    Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.
    Tomazin R; Boname J; Hegde NR; Lewinsohn DM; Altschuler Y; Jones TR; Cresswell P; Nelson JA; Riddell SR; Johnson DC
    Nat Med; 1999 Sep; 5(9):1039-43. PubMed ID: 10470081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.
    Rehm KE; Connor RF; Jones GJ; Yimbu K; Mannie MD; Roper RL
    Immunology; 2009 Nov; 128(3):381-92. PubMed ID: 20067538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral interference with antigen presentation.
    Yewdell JW; Hill AB
    Nat Immunol; 2002 Nov; 3(11):1019-25. PubMed ID: 12407410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.
    Sievers E; Neumann J; Raftery M; SchOnrich G; Eis-Hübinger AM; Koch N
    Immunology; 2002 Sep; 107(1):129-35. PubMed ID: 12225371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alphaherpesvirus gB Homologs Are Targeted to Extracellular Vesicles, but They Differentially Affect MHC Class II Molecules.
    Grabowska K; Wąchalska M; Graul M; Rychłowski M; Bieńkowska-Szewczyk K; Lipińska AD
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32290097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of MHC II antigen presentation by ubiquitination.
    Moffat JM; Mintern JD; Villadangos JA
    Curr Opin Immunol; 2013 Feb; 25(1):109-14. PubMed ID: 23183035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope.
    Deng J; Lu C; Liu C; Oveissi S; Fairlie WD; Lee EF; Bilsel P; Puthalakath H; Chen W
    FEBS J; 2021 May; 288(10):3164-3185. PubMed ID: 33830641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts.
    Vasireddi M; Hilliard J
    J Virol; 2012 Dec; 86(23):12503-11. PubMed ID: 22973043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1.
    Trgovcich J; Johnson D; Roizman B
    J Virol; 2002 Jul; 76(14):6974-86. PubMed ID: 12072498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Velásquez LN; Milillo MA; Delpino MV; Trotta A; Fernández P; Pozner RG; Lang R; Balboa L; Giambartolomei GH; Barrionuevo P
    J Leukoc Biol; 2017 Mar; 101(3):759-773. PubMed ID: 27765819
    [No Abstract]   [Full Text] [Related]  

  • 34. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse immune evasion strategies by human cytomegalovirus.
    Noriega V; Redmann V; Gardner T; Tortorella D
    Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC presentation via autophagy and how viruses escape from it.
    Gannage M; Münz C
    Semin Immunopathol; 2010 Dec; 32(4):373-81. PubMed ID: 20857294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.
    Mulder DJ; Pooni A; Mak N; Hurlbut DJ; Basta S; Justinich CJ
    Am J Pathol; 2011 Feb; 178(2):744-53. PubMed ID: 21281807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation.
    Forsyth KS; Eisenlohr LC
    Curr Opin Immunol; 2016 Jun; 40():123-9. PubMed ID: 27115617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
    Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
    J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
    Matsuzaki J; Tsuji T; Luescher I; Old LJ; Shrikant P; Gnjatic S; Odunsi K
    Cancer Immunol Res; 2014 Apr; 2(4):341-50. PubMed ID: 24764581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.